Oncostatin M: Risks and benefits of a Novel Therapeutic Target for Atherosclerosis.
Sign Up to like & getrecommendations! Published in 2022 at "Current drug targets"
DOI: 10.2174/1389450123666220811101032
Abstract: BACKGROUND Cardiovascular disease (CVD) is a leading cause of death worldwide. It is predicted that approximately 23.6 million people will die from CVDs annually by 2030. Therefore, there is a great need for an effective… read more here.
Keywords: therapeutic target; target atherosclerosis; oncostatin risks; atherosclerosis ... See more keywords